Patrick Brown is an Oncology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Sponsor: National Cancer Institute (NCI)
- Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
Sponsor: New York State Psychiatric Institute
- Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AmgenProgram year20251 paymentResearch$253,435openpaymentsdata.cms.gov ↗
- AmgenProgram year20241 paymentResearch$1,137,457openpaymentsdata.cms.gov ↗
- AmgenProgram year20233 paymentsResearch$257,324openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
1 NIH research award on record, funded 2006–2010 per NIH RePORTER. The latest:
- Developing FLT3-Targeted Therapy for Pediatric Leukemia
Johns Hopkins University
FY2010$140,130K23CA111728 - Developing FLT3-Targeted Therapy for Pediatric Leukemia
Johns Hopkins University
FY2009$140,130K23CA111728 - Developing FLT3-Targeted Therapy for Pediatric Leukemia
Johns Hopkins University
FY2008$140,130K23CA111728
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”